- Home
- LMFA vs NEUP Comparison
LMFA vs NEUP Comparison
Compare LMFA & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- NEUP
- Stock Information
- Founded
- LMFA 2008
- NEUP 1996
- Country
- LMFA United States
- NEUP United States
- Employees
- LMFA N/A
- NEUP N/A
- Industry
- LMFA Finance: Consumer Services
- NEUP
- Sector
- LMFA Finance
- NEUP
- Exchange
- LMFA Nasdaq
- NEUP Nasdaq
- Market Cap
- LMFA 11.9M
- NEUP 12.7M
- IPO Year
- LMFA 2015
- NEUP N/A
- Fundamental
- Price
- LMFA $1.14
- NEUP $11.92
- Analyst Decision
- LMFA Strong Buy
- NEUP Strong Buy
- Analyst Count
- LMFA 1
- NEUP 1
- Target Price
- LMFA $5.00
- NEUP $21.00
- AVG Volume (30 Days)
- LMFA 603.5K
- NEUP 64.8K
- Earning Date
- LMFA 08-14-2025
- NEUP 08-28-2025
- Dividend Yield
- LMFA N/A
- NEUP N/A
- EPS Growth
- LMFA N/A
- NEUP N/A
- EPS
- LMFA N/A
- NEUP 0.00
- Revenue
- LMFA $6,755,925.00
- NEUP $15,662,715.00
- Revenue This Year
- LMFA N/A
- NEUP N/A
- Revenue Next Year
- LMFA $6.50
- NEUP N/A
- P/E Ratio
- LMFA N/A
- NEUP $7,062.98
- Revenue Growth
- LMFA N/A
- NEUP N/A
- 52 Week Low
- LMFA $1.02
- NEUP $2.90
- 52 Week High
- LMFA $5.14
- NEUP $126.00
- Technical
- Relative Strength Index (RSI)
- LMFA 33.52
- NEUP 67.66
- Support Level
- LMFA $1.25
- NEUP $6.82
- Resistance Level
- LMFA $1.34
- NEUP $13.25
- Average True Range (ATR)
- LMFA 0.13
- NEUP 1.26
- MACD
- LMFA -0.04
- NEUP 0.51
- Stochastic Oscillator
- LMFA 6.16
- NEUP 78.24
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.